SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,695.00    245.00 (5.51%)
Bid:
4,670.00
Ask:
4,720.00
Spread: 50.00 (1.071%)
Market Cap: £312.72m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Update

20 Jul 2016 07:00

RNS Number : 6631E
Judges Scientific PLC
20 July 2016
 

Press Release

20 July 2016

 

Judges Scientific Plc

("Judges Scientific" or "the Group")

Trading Update

 

Further to the AGM statement released on 25 May 2016, the Directors of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, update shareholders and the market regarding the Group's trading performance during the first half of the current financial year.

The Group's results for the six-month period to 30 June 2016 will include a full contribution from Armfield Limited (against 23 weeks in the first half of 2015) and the post-acquisition contribution from CoolLED Limited and Dia-Stron Limited which were acquired in the first quarter of 2016. "Organic" in this statement excludes both the performance of Armfield and the more recent acquisitions.

Order intake

For the third year in a row, order intake in the first quarter was weak; this lasted until the end of May and was followed by a healthy rebound with five consecutive weeks of strong bookings narrowing the decline in Organic order intake for the first half to only 1.6% below 2015. The Organic order book finished the first half at 10.7 weeks of sales against 11.7 weeks at 30th June 2015 and 11.4 weeks at the beginning of the period.

Following a very strong year in 2015, Armfield experienced low order intake until the end of May and, although it also recovered in June, it is well below the first half of 2015. Management believes that this reduction in orders has been influenced by the weak price of oil and other commodities and their impact on public funding in many developing economies.

For the Group as a whole, order intake was down 3.4% compared with the first half of 2015 and the order book stood at 10.6 weeks at 30th June 2016.

First Half Performance

The timing of the recovery in order intake prevented the improved bookings from translating into a satisfactory sales performance for the period to 30 June 2016; this was compounded by production issues at one of the companies in our vacuum segment. As a consequence revenues, EBIT and earnings per share for the first half will be down on 2015.

Full Year Outlook

The recent revival in order intake and the positive impact of a weaker pound post Brexit give the Board confidence that the second half will produce better results, however it will be difficult to claw back the underperformance of the first half, as indicated in the AGM statement. The Board now believes that earnings per share for the full year will be substantially below market expectations.

 

- Ends -

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Abchurch (Financial Public Relations)

 

Canace Wong

Nessyah Hart

Julian Bosdet

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDDAIALIR
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.